VIVEbiotech — Series A · approximately €1M

CDTI took an equity stake of over €1M through its Innvierte programme, investing alongside Inveready Biotech III and EASO Ventures. Together with the €3.5M private raise from 2019, this made up the €4.5M financing for the new production centre. It was announced as capital entry, not as a loan.

LeadCDTI (Innvierte) RoundSeries A Announced16 Jul 2020 CitySan Sebastián SectorHealthtech & Bio · Biotech / Cell and gene therapy CDMO Source

Something wrong? Suggest a correction →

The company

Investors 3

← All funding rounds

Start typing to search across everything.
↑↓ navigate↵ openesc close? shortcuts
Keyboard shortcuts
/ Ctrl K
Search
j k
Next or previous row
↵
Open the row
Ctrl ↵
Open it in a new tab
[ ]
Previous or next page
?
This list